DexCom (DXCM) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

DexCom Revenue Highlights


Latest Revenue (Y)

$3.62B

Latest Revenue (Q)

$994.20M

Main Geography (Y)

UNITED STATES

DexCom Revenue by Period


DexCom Revenue by Year

DateRevenueChange
2023-12-31$3.62B24.49%
2022-12-31$2.91B18.84%
2021-12-31$2.45B27.08%
2020-12-31$1.93B30.54%
2019-12-31$1.48B43.08%
2018-12-31$1.03B43.58%
2017-12-31$718.50M25.33%
2016-12-31$573.30M42.61%
2015-12-31$402.00M55.09%
2014-12-31$259.20M62.00%
2013-12-31$160.00M60.16%
2012-12-31$99.90M30.99%
2011-12-31$76.27M56.83%
2010-12-31$48.63M63.78%
2009-12-31$29.69M201.82%
2008-12-31$9.84M112.62%
2007-12-31$4.63M113.25%
2006-12-31$2.17M100.00%
2005-12-31-100.00%
2004-12-31-100.00%
2003-12-31-100.00%
2002-12-31-100.00%
2001-12-31-100.00%
2000-12-31--

DexCom generated $3.62B in revenue during NA 2023, up 24.49% compared to the previous quarter, and up 351.13% compared to the same period a year ago.

DexCom Revenue by Quarter

DateRevenueChange
2024-09-30$994.20M-1.01%
2024-06-30$1.00B9.04%
2024-03-31$921.00M-10.97%
2023-12-31$1.03B6.10%
2023-09-30$975.00M11.90%
2023-06-30$871.30M17.51%
2023-03-31$741.50M-9.04%
2022-12-31$815.20M5.93%
2022-09-30$769.60M10.54%
2022-06-30$696.20M10.72%
2022-03-31$628.80M-9.94%
2021-12-31$698.20M7.38%
2021-09-30$650.20M9.26%
2021-06-30$595.10M17.84%
2021-03-31$505.00M-11.23%
2020-12-31$568.90M13.58%
2020-09-30$500.90M10.87%
2020-06-30$451.80M11.53%
2020-03-31$405.10M-12.47%
2019-12-31$462.80M16.78%
2019-09-30$396.30M17.81%
2019-06-30$336.40M19.93%
2019-03-31$280.50M-17.01%
2018-12-31$338.00M26.73%
2018-09-30$266.70M9.98%
2018-06-30$242.50M31.51%
2018-03-31$184.40M-16.56%
2017-12-31$221.00M19.72%
2017-09-30$184.60M8.21%
2017-06-30$170.60M19.89%
2017-03-31$142.30M-16.88%
2016-12-31$171.20M15.21%
2016-09-30$148.60M8.23%
2016-06-30$137.30M18.16%
2016-03-31$116.20M-11.16%
2015-12-31$130.80M24.33%
2015-09-30$105.20M12.88%
2015-06-30$93.20M28.02%
2015-03-31$72.80M-13.64%
2014-12-31$84.30M22.17%
2014-09-30$69.00M17.35%
2014-06-30$58.80M24.84%
2014-03-31$47.10M-8.90%
2013-12-31$51.70M20.51%
2013-09-30$42.90M19.83%
2013-06-30$35.80M20.95%
2013-03-31$29.60M-11.02%
2012-12-31$33.27M44.08%
2012-09-30$23.09M-1.54%
2012-06-30$23.45M16.70%
2012-03-31$20.09M-10.37%
2011-12-31$22.42M22.83%
2011-09-30$18.25M-14.77%
2011-06-30$21.42M51.10%
2011-03-31$14.17M-9.35%
2010-12-31$15.64M34.05%
2010-09-30$11.66M-1.04%
2010-06-30$11.79M23.48%
2010-03-31$9.54M-8.84%
2009-12-31$10.47M44.25%
2009-09-30$7.26M7.52%
2009-06-30$6.75M29.53%
2009-03-31$5.21M27.96%
2008-12-31$4.07M112.14%
2008-09-30$1.92M-3.13%
2008-06-30$1.98M6.44%
2008-03-31$1.86M-

DexCom generated $994.20M in revenue during Q3 2024, up -1.01% compared to the previous quarter, and up 114.11% compared to the same period a year ago.

DexCom Revenue Breakdown


DexCom Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
UNITED STATES$2.63B$2.14B$1.85B$1.51B$1.16B
Non-US$997.00M$767.80M$599.10M$417.20M$314.50M

DexCom's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (72.48%), and Non-US (27.52%).

Quarterly Revenue by Country

CountrySep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Non-US$292.30M$272.40M$265.40M$261.40M$254.70M$215.50M$208.80M$196.20M$185.20M$177.60M$181.10M$160.60M$133.60M$123.80M$117.40M$102.30M$84.70M$112.80M$86.90M$87.50M
UNITED STATES$701.90M$731.90M$769.10M$713.60M$616.60M$526.00M$606.40M$573.40M$511.00M$451.20M$517.10M$489.60M$461.50M$381.20M$451.50M$398.60M$367.10M$292.30M$375.90M$308.80M

DexCom's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (70.60%), and Non-US (29.40%).

DexCom Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
ABTAbbott Laboratories$40.11B$10.63B
MDTMedtronic$32.36B$7.92B
EWEdwards Lifesciences$6.00B$1.39B
DXCMDexCom$3.62B$994.20M
ZBHZimmer Biomet$1.94B$143.40M
PODDInsulet$1.70B$488.50M
IARTIntegra LifeSciences$1.54B$418.18M
PENPenumbra$1.06B$301.04M
TNDMTandem Diabetes Care$747.72M$331.03M
SWAVShockWave Medical$730.23M$218.81M
INSPInspire Medical Systems$624.80M$195.88M
INMDInMode$492.05M$80.28M

DXCM Revenue FAQ


DexCom's yearly revenue for 2023 was $3.62B, representing an increase of 24.49% compared to 2022. The company's yearly revenue for 2022 was $2.91B, representing an increase of 18.84% compared to 2021. DXCM's yearly revenue for 2021 was $2.45B, representing an increase of 27.08% compared to 2020.

DexCom's quarterly revenue for Q3 2024 was $994.2M, a -1.01% decrease from the previous quarter (Q2 2024), and a 1.97% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1B, a 9.04% increase from the previous quarter (Q1 2024), and a 15.26% increase year-over-year (Q2 2023). DXCM's quarterly revenue for Q1 2024 was $921M, a -10.97% decrease from the previous quarter (Q4 2023), and a 24.21% increase year-over-year (Q1 2023).

DexCom's revenue growth rate for the last 3 years (2021-2023) was 47.94%, and for the last 5 years (2019-2023) was 145.41%.